Top Buy Now Summary References
Home
>
Section
>
Chapter

Rapid titration of VNS therapy reduces time-to-response in epilepsy

Tzadok, M.; Verner, R.; Kann, L.; Tungala, D.; Gordon, C.; El Tahry, R.ëm.; Fahoum, F.

Epilepsy and Behavior E&b 134: 108861

2022

ISSN/ISBN: 1525-5069
PMID: 35963047
Accession: 080190215

Article/Abstract emailed within 1 workday
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Summary
Common titration strategies for vagus nerve stimulation (VNS) prioritize monitoring of tolerability during small increases in stimulation intensity over several months. Prioritization of tolerability is partially based on how quickly side effects can be perceived and reported by patients, and the delayed onset of clinical benefits from VNS. However, many practices assess the clinical benefit of VNS at one year after implantation, and excessive caution during the titration phase can significantly delay target dosing or prevent a patient from reaching a therapeutic dose entirely. This study aimed to characterize the relationship between titration speed and the onset of clinical response to VNS. To assess differences between more aggressive titration strategies and more conservative ones, we analyzed the relationship between time-to-dose and time-to-response using a weighted Cox regression. The target dose was empirically defined as 1.625 mA output current delivered at 250 microsecond pulse widths at 20 Hz. Patient-level outcomes and dosing data were segregated into fast (<3 months), medium (3-6 months), and slow (>6 months) cohorts based on their titration speed. The statistical model revealed a significant relationship between titration speed and onset of clinical response, defined as a 50% reduction from baseline in seizure frequency. Frequency of adverse events reported between each cohort trended toward higher rates of adverse events in adults who were titrated quickly; however, the pediatric population appeared to be more tolerant of titration at any speed. This analysis indicates that faster titration yields faster onset of clinical benefit and is especially practical in the pediatric population, though attempts to accelerate adult titration may still be warranted.

References

Kaneko, S.; Inoue, Y.; Sasagawa, M.; Kato, M. 2012: Titration comparative study of TOPINA Tablets in patients with localization related epilepsy: double-blind comparative study by rapid and slow titration methods Nihon Shinkei Seishin Yakurigaku Zasshi 32(2): 73-83
Jang, Y.; Moon, J.; Kim, N.; Kim, T.-J.; Jun, J.-S.; Shin, Y.-W.; Chang, H.; Kang, H.-R.; Lee, S.-T.; Jung, K.-H.; Park, K.-I.; Jung, K.-Y.; Chu, K.; Lee, S.K. 2021: A new rapid titration protocol for lamotrigine that reduces the risk of skin rash Epilepsia Open 6(2): 394-401
Kluger, G.; Schäuble, B.; Rettig, K.; Schreiner, A.; Holthausen, H. 2009: Effectiveness of low dose of topiramate following rapid titration in multiply handicapped children and difficult-to-treat epilepsy Neuropediatrics 40(2): 61-65
Sarrazin, C.; Shiffman, M.L.; Hadziyannis, S.J.; Lin, A.; Colucci, G.; Ishida, H.; Zeuzem, S. 2010: Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy Journal of Hepatology 52(6): 832-838
Sundararajan, K.; Flabouris, A.; Keeshan, A.; Cramey, T. 2014: Documentation of limitation of medical therapy at the time of a rapid response team call Australian Health Review: a Publication of the Australian Hospital Association 38(2): 218-222
Kivity, S.; Shorer, Z.; Unit, S. 1999: Lamotrigine add-on therapy in children with drug-resistant epilepsy Low incidence of rash associated with low initial and titration doses Epilepsia 40(Suppl 2): 172
Yalçin, S.Songül. 2010: Prophylactic paracetamol at the time of infant vaccination reduces the risk of fever, but also reduces antibody response Evidence-Based Nursing 13(3): 76-77
Akhtar, M.; Peterson, K.L.; Phillips, P.S.; Ben Yehuda, O. 2004: Initial response to statin therapy predicts response to dose titration Journal of the American College of Cardiology 43(5 Suppl A): 479A-480A
Salvatierra, G.G.; Bindler, R.C.; Daratha, K.B. 2016: Rapid Response Teams: Is it Time to Reframe the Questions of Rapid Response Team Measurement? Journal of Nursing Scholarship: An Official Publication of Sigma Theta Tau International Honor Society of Nursing 48(6): 616-623
Hitchman, R.B.; Siaterli, E.A.; Nixon, C.P.; King, L.A. 2007: Quantitative real-time PCR for rapid and accurate titration of recombinant baculovirus particles Biotechnology and Bioengineering 96(4): 810-814
Di Trani, J.M.; Moitessier, N.; Mittermaier, A.K. 2017: Measuring Rapid Time-Scale Reaction Kinetics Using Isothermal Titration Calorimetry Analytical Chemistry 89(13): 7022-7030
Homme, J.H.; Fischer, P.R. 2010: Randomised controlled trial: Prophylactic paracetamol at the time of infant vaccination reduces the risk of fever but also reduces antibody response Evidence-Based Medicine 15(2): 50-51
Pae, C-Un.; Nassir Ghaemi, S.; Kim, T-Suk.; Kim, J-Jin.; Lee, S-Jung.; Lee, C-Uk.; Lee, C.; Paik, I-Ho. 2005: Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: a preliminary trial International Clinical Psychopharmacology 20(6): 327-330
Berger, A.; Carapancea, E.; Vespa, S.; Danthine, V.; Doguet, P.; Delbeke, J.; Nonclercq, A.; El Tahry, R.ëm. 2023: Vagus nerve stimulation-induced laryngeal motor evoked potentials for response prediction and intensity titration in drug-resistant epilepsy Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 147: 99-107
Moeller, S.; Wang, R.; Aydin, M.; Lam, A.P.; Sitter, A.; Grüter, J.; Philipsen, A.; Müller, H.H.O. 2020: Rapid titration protocol - Experiences with a dynamic novel titration regime for vagus nerve stimulation in a group of depressive patients Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 74: 262-264
Rusing, E. 1996: Rapid Prototyping : Dienstleistung spart Entwicklungszeit - Rapid prototyping: performance reduces the development time Vdi-Z 138(6): 84-86
Broekaart, D.W.M.; Zimmer, T.S.; Cohen, S.T.; Tessers, R.; Anink, J.J.; de Vries, H.E.; Gorter, J.A.; Prades, R.; Aronica, E.; van Vliet, E.A. 2022: The Gelatinase Inhibitor ACT-03 Reduces Gliosis in the Rapid Kindling Rat Model of Epilepsy, and Attenuates Inflammation and Loss of Barrier Integrity in Vitro Biomedicines 10(9)